smallpox vaccine LC16m8

attenuated tissue-cultured smallpox vaccine

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

1.	Mpox (monkeypox) 07/24/2017 - "A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox."
2.	Vaccinia 03/11/2009 - "The attenuated, tissue-cultured, third-generation smallpox vaccine LC16m8 was administered to vaccinia-naive infants in Japan during the 1970s without serious adverse events. " 03/11/2009 - "Administration of an attenuated tissue-cultured smallpox vaccine (LC16m8) to healthy adults was associated with high levels of vaccine take and seroconversion in those who were vaccinia-naive and yielded an effective booster response in some previously vaccinated individuals." 11/01/2009 - "Human vaccinia immune globulin was used to screen the secreted proteins from cells infected with Dryvax or the candidate smallpox vaccine LC16m8 to determine whether the protective humoral response included antibodies against secreted viral proteins. "

1.	Viral Proteins
2.	Vaccines
3.	Proteins (Proteins, Gene)
4.	Immunoglobulins (Immunoglobulin)
5.	Antibodies